Solventum (SOLV) Earnings Analysis
Solventum (SOLV) has no confirmed upcoming earnings date. Last quarter (2026-02-26) it beat with EPS 1.57 USD vs 1.5 USD est (+4.7%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 9.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SOLV next report earnings?
No confirmed upcoming earnings date is currently scheduled for SOLV. This page updates as the calendar is published.
SOLV earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | 1.57 USD | 1.5 USD | +4.7% | Beat |
| 2025-11-06 | 1.5 USD | 1.43 USD | +4.9% | Beat |
| 2025-08-07 | 1.69 USD | 1.45 USD | +16.6% | Beat |
| 2025-05-08 | 1.34 USD | 1.21 USD | +10.7% | Beat |
| 2025-02-27 | 1.41 USD | 1.31 USD | +7.6% | Beat |
| 2024-11-07 | 1.64 USD | 1.39 USD | +18% | Beat |
| 2024-08-08 | 1.56 USD | 1.51 USD | +3.3% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
SOLV valuation and analyst view
| Trailing P/E | 9.46 |
|---|---|
| Trailing EPS | 8.22 USD |
| Price / book | 2.72 |
| Dividend yield | 0.00% |
| Market cap | 13.50B |
| Analyst consensus | Buy (7 buy / 3 hold / 1 sell) |
| Avg price target | 82.75 USD |
Related research pages
Frequently asked questions
When is Solventum (SOLV)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for SOLV. This page updates as the calendar is published.
Did SOLV beat earnings last quarter?
In its 2026-02-26 report, SOLV posted EPS of 1.57 USD versus a 1.5 USD estimate — a beat of 4.7%.
What is SOLV's earnings track record?
Over the last 7 reported quarters with consensus data, SOLV beat estimates 7 times (100%).
What is SOLV's current P/E ratio and EPS?
SOLV trades at a trailing P/E of 9.46 on trailing EPS of 8.220436280137772 USD.
What do analysts rate SOLV?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 7 buy, 3 hold, 1 sell, 0 strong sell). Average 12-month price target: 82.75 USD.